Data / Federal rules / 2024-04751
Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Addition to List of Standing Committees
The Food and Drug Administration published this final rule in the Federal Register on March 6, 2024. It took effect on March 6, 2024.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Food and Drug Administration (FDA or Agency) is amending the standing advisory committee regulations to add the establishment of the Genetic Metabolic Diseases Advisory Committee (GeMDAC or the Committee) to the list of standing committees.
Key facts
- Document number
- 2024-04751
- Type
- Final rule
- Action
- Final rule
- Agency
- Health and Human Services Department; Food and Drug Administration
- Published
- March 6, 2024
- Takes effect
- March 6, 2024
- Dates
- This rule is effective March 6, 2024.
- Docket
- Docket No. FDA-2024-N-0826
- Code of Federal Regulations
- 21 CFR 14
- Topics
- Administrative practice and procedure; Advisory committees; Color additives; Drugs; Radiation protection
- Pages
- 1
Other documents from the Food and Drug Administration
Everything from the Food and Drug Administration · Rules on administrative practice and procedure · Rules on advisory committees · Rules on color additives · Published in March 2024
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.